Effects of tea polyphenols on hepatic fibrosis in rats with alcoholic liver disease

被引:2
|
作者
You-Ming Li
机构
关键词
hepatic fibrosis; tea polyphenols; rat;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
BACKGROUND: As an anti-oxidation agent, tea polyphe- nols may have the effect of anti-fibrosis. This study was de- signed to observe the effect of tea polyphenols on hepatic fi- brosis in rats with alcoholic liver disease and to explore the related mechanisms. METHODS: Sixty healthy Sprague-Dawley rats were divided randomly into normal control group, single alcohol group, and three alcohol groups given different doses of tea poly- phenols. Alcohol or isovolumic normal saline and corre- sponding doses of tea polyphenols were given daily to the rats separately. The rats were sacrificed at the end of the 24th week. Masson staining was performed to observe liver fibrosis, serum endotoxin, and oxidant and anti-oxidant activity. RESULTS: Hepatic fibrosis was less severe in the rats of the alcohol groups given tea polyphenols than in the single al- cohol group. Tea polyphenols increased the serum anti- oxidant capacity and decreased the endotoxin level. CONCLUSION: Tea polyphenols show anti-fibrosis effect in rats with alcoholic liver disease, and the mechanism may be related to the clearance of overall oxidant and decrease of the endotoxin level. (Hepatobiliary Pancreat Dis Int 2004; 3: 577
引用
收藏
页码:577 / 579
页数:3
相关论文
共 50 条
  • [21] HEPATIC MACROPHAGES IN ALCOHOLIC LIVER DISEASE
    Wang, M.
    Gao, B.
    Ju, C.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 257A - 257A
  • [22] Inhibitory effect of tea polyphenols on hepatic preneoplastic foci in Wistar rats
    Srivastava, Smita
    Singh, Madhulika
    Roy, Preeti
    Prasad, Sahdeo
    George, Jasmine
    Shukla, Yogeshwer
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (06) : 526 - 533
  • [23] Inhibitory effect of tea polyphenols on hepatic preneoplastic foci in Wistar rats
    Smita Srivastava
    Madhulika Singh
    Preeti Roy
    Sahdeo Prasad
    Jasmine George
    Yogeshwer Shukla
    Investigational New Drugs, 2009, 27 : 526 - 533
  • [24] The impact of alcohol consumption on hepatic fibrosis in non-alcoholic fatty liver disease
    Mitchell, T.
    Jeffrey, G. P.
    Macquillan, G.
    Garas, G.
    Ching, H.
    Hamdorf, J.
    Adams, L. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 110 - 111
  • [25] The impact of alcohol consumption on hepatic fibrosis in non-alcoholic fatty liver disease
    Mitchell, Tim
    Jeffrey, Gary P.
    MacQuillan, Gerry C.
    Garas, George
    Ching, Helena
    Hamdorf, Jeffrey M.
    Adams, Leon A.
    HEPATOLOGY, 2016, 64 : 548A - 548A
  • [26] Characterization of portal inflammation and hepatic fibrosis in non-alcoholic fatty liver disease
    Masters, Annie
    Estep, James M.
    Alaparthi, Lakshmi
    Bratthauer, Gary
    Birerdinc, Aybike
    Monge, Fanny
    Sharp, Cassandra
    Tan, Daisong
    Abdelaal, Hala
    Goodman, Zachary
    Younossi, Zobair
    JOURNAL OF HEPATOLOGY, 2023, 78 : S782 - S783
  • [27] Transient elastography alone and in combination with FibroTest® for the diagnosis of hepatic fibrosis in alcoholic liver disease
    Voican, Cosmin Sebastian
    Louvet, Alexandre
    Trabut, Jean-Baptiste
    Njike-Nakseu, Micheline
    Dharancy, Sebastien
    Sanchez, Andrea
    Corouge, Marion
    Lamouri, Karima
    Lebrun, Amandine
    Balian, Axel
    Prevot, Sophie
    Lachgar, Mounia
    Maitre, Sophie
    Agostini, Helene
    Mathurin, Philippe
    Perlemuter, Gabriel
    Naveau, Sylvie
    LIVER INTERNATIONAL, 2017, 37 (11) : 1697 - 1705
  • [28] Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease
    Pavlov, Chavdar S.
    Casazza, Giovanni
    Nikolova, Dimitrinka
    Tsochatzis, Emmanuel
    Burroughs, Andrew K.
    Ivashkin, Vladimir T.
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01):
  • [29] Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis
    Pares, A
    Deulofeu, R
    Gimenez, A
    Caballeria, L
    Bruguera, M
    Caballeria, J
    Ballesta, AM
    Rodes, J
    HEPATOLOGY, 1996, 24 (06) : 1399 - 1403
  • [30] Effects of polyphenols on non-alcoholic fatty liver disease: a case study of resveratrol
    Zhao, Ying
    Ren, Jiali
    Chen, Weisan
    Gao, Xinchen
    Yu, Hongjian
    Li, Xiankuan
    Zheng, Yanchao
    Yang, Jinlong
    FOOD & FUNCTION, 2025,